(R)-1-(4-Iodophenyl)ethanamine hydrochloride
95%
- Product Code: 87145
CAS:
1246649-06-8
| Molecular Weight: | 283.54 g./mol | Molecular Formula: | C₈H₁₁ClIN |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD12756020 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, inert gas storage |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs), particularly those targeting neurological and psychiatric disorders. Its chiral structure makes it valuable in the production of enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Additionally, it is employed in the development of radiopharmaceuticals for diagnostic imaging, leveraging its iodine component for radiolabeling purposes. In organic chemistry, it is also used as a building block for the preparation of complex molecules, aiding in the study of drug-receptor interactions and the optimization of therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $222.77 |
+
-
|
| 0.250 | 10-20 days | $356.17 |
+
-
|
| 1.000 | 10-20 days | $890.28 |
+
-
|
(R)-1-(4-Iodophenyl)ethanamine hydrochloride
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs), particularly those targeting neurological and psychiatric disorders. Its chiral structure makes it valuable in the production of enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Additionally, it is employed in the development of radiopharmaceuticals for diagnostic imaging, leveraging its iodine component for radiolabeling purposes. In organic chemistry, it is also used as a building block for the preparation of complex molecules, aiding in the study of drug-receptor interactions and the optimization of therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :